Lisocabtagene maraleucel delivers sustained survival benefits and long-term disease control in relapsed or refractory LBCL.
The post Improved Long-Term Results With Liso-Cel in LBCL first appeared on Physician’s Weekly.
Improved Long-Term Results With Liso-Cel in LBCL
Leave a Reply
We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.